APA (7th ed.) Citation

G, F., I, Z., R, C., P, V., & D, B. (2018). Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials. Frontiers in immunology, 9, 1169. https://doi.org/10.3389/fimmu.2018.01169

Chicago Style (17th ed.) Citation

G, Flórez-Grau, Zubizarreta I, Cabezón R, Villoslada P, and Benitez-Ribas D. "Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials." Frontiers in Immunology 9 (2018): 1169. https://doi.org/10.3389/fimmu.2018.01169.

MLA (9th ed.) Citation

G, Flórez-Grau, et al. "Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials." Frontiers in Immunology, vol. 9, 2018, p. 1169, https://doi.org/10.3389/fimmu.2018.01169.